Art
J-GLOBAL ID:200902245254788788   Reference number:09A0210873

Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy

BCG膀胱内療法後の膀胱癌検出における細胞診,膀胱鏡検査,生検の間の不一致
Author (9):
Material:
Volume: 16  Issue:Page: 192-195  Publication year: Feb. 2009 
JST Material Number: W1347A  ISSN: 0919-8172  Document type: Article
Article type: 原著論文  Country of issue: Australia (AUS)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0210873&from=J-GLOBAL&jstjournalNo=W1347A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Urologenital system diagnosis 
Reference (16):
  • VAN DER MEIJDEN, APM. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur. Urol. 2005, 48, 363-371
  • LAMM, DL. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, Tl and carcinoma in situ transitional cell carcinoma of the bladder : A randomized Southwest Oncology Group study. J. Urol. 2000, 163, 1124-1129
  • JAKSE, G. Intravesical BCG in patients with carcinoma in situ of the urinary bladder : Long-term results of EORTC GU Group Phase II Protocol 30861. Eur. Urol. 2001, 40, 144-150
  • ZAAK, D. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer. 2002, 95, 1234-1238
  • GUY, L. Should bladder biopsies be performed routinely after Bacillus Calmette-Guerin treatment for high-risk superficial transitional cell cancer of the bladder?. Eur. Urol. 2006, 50, 516-520
more...

Return to Previous Page